β-Arrestin 2 knockout prevents bone loss in response to continuous parathyroid hormone stimulation in male and female mice

References

• Goltzman D, Mannstadt M, Marcocci C. Physiology of the calcium-parathyroid hormone-vitamin D axis. Front Horm Res. 2018;50:1–13. doi:10.1159/000486060.
   PubMed Web of Science ®Google Scholar
• Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. J Clin Endocrinol Metab. 1997 Feb;82(2):620–628. doi:10.1210/jc.82.2.620.
   PubMed Web of Science ®Google Scholar
• Reginster JY, Al Daghri NM, Bruyere O. Abaloparatide comparator trial in vertebral endpoints (ACTIVE) confirms that abaloparatide is a valuable addition to the armamentarium against osteoporosis. Expert Opin Pharmacother. 2017 Dec;18(17):1811–1813. doi:10.1080/14656566.2017.1395021.
   PubMed Web of Science ®Google Scholar
• Silverberg SJ, Shane E, de la Cruz L, Dempster DW, Feldman F, Seldin D, Jacobs TP, Siris ES, Cafferty M, Parisien MV. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res. 1989;4(3):283–291. doi:10.1002/jbmr.5650040302.
   PubMed Web of Science ®Google Scholar
• Vestergaard P, Mosekilde L. Fractures in patients with primary hyperparathyroidism: nationwide follow- up study of 1201 patients. World J Surg. 2003;27(3):343–349. doi:10.1007/s00268-002-6589-9.
   PubMed Web of Science ®Google Scholar
• Insogna KL. Primary hyperparathyroidism. N Engl J Med. 2018 Sep 13;379(11):1050–1059. doi:10.1056/NEJMcp1714213.
   PubMed Web of Science ®Google Scholar
• Abou-Samra AB, Juppner H, Force T, Freeman MW, Kong XF, Schipani E, Urena P, Richards J, Bonventre JV, Potts JT Jr., Kronenberg HM, Segre GV. Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc Natl Acad Sci U S A. 1992;89(7):2732–2736. doi:10.1073/pnas.89.7.2732.
   PubMed Web of Science ®Google Scholar
• Fan Y, Hanai JI, Le PT, Bi R, Maridas D, DeMambro V, Figueroa CA, Kir S, Zhou X, Mannstadt M, Baron R, Bronson RT, Horowitz MC, Wu JY, Bilezikian JP, Dempster DW, Rosen CJ, Lanske B. Parathyroid hormone directs bone marrow mesenchymal cell fate. Cell Metab. 2017 Mar 7;25(3):661–672. doi:10.1016/j.cmet.2017.01.001.
   PubMed Web of Science ®Google Scholar
• Hausmann S, Law FM, Bonjour JP, Feyen J, Rizzoli R. Regulation of parathyroid hormone/parathyroid hormone-related protein receptor expression by osteoblast-deposited extracellular matrix in a human osteoblast-like cell line. J Cell Physiol. 1995 Oct;165(1):164–171. doi:10.1002/jcp.1041650119.
   PubMed Web of Science ®Google Scholar
• Suttamanatwong S, Jensen ED, Schilling J, Franceschi RT, Carlson AE, Mansky KC, Gopalakrishnan R. Sp proteins and Runx2 mediate regulation of matrix gla protein (MGP) expression by parathyroid hormone. J Cell Biochem. 2009 May 15;107(2):284–292. doi:10.1002/jcb.22124.
   PubMed Web of Science ®Google Scholar
• Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD, Nissenson RA. PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res. 2004 Feb;19(2):235–244. doi:10.1359/JBMR.0301226.
   PubMed Web of Science ®Google Scholar
• Ma YL, Cain RL, Halladay DL, Yang X, Zeng Q, Miles RR, Chandrasekhar S, Martin TJ, Onyia JE. Catabolic effects of continuous human PTH (1–38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology. 2001 Sep;142(9):4047–4054. doi:10.1210/endo.142.9.8356.
   PubMed Web of Science ®Google Scholar
• Tawfeek HA, Qian F, Abou-Samra AB. Phosphorylation of the receptor for PTH and PTHrP is required for internalization and regulates receptor signaling. Mol Endocrinol. 2002 Jan;16(1):1–13. doi:10.1210/mend.16.1.0760.
   PubMed Web of Science ®Google Scholar
• Chauvin S, Bencsik M, Bambino T, Nissenson RA. Parathyroid hormone receptor recycling: role of receptor dephosphorylation and beta-arrestin. Mol Endocrinol. 2002;16(12):2720–2732. doi:10.1210/me.2002-0049.
   PubMedGoogle Scholar
• Benovic JL, Kühn H, Weyand I, Codina J, Caron MG, Lefkowitz RJ. Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein). Proc Natl Acad Sci U S A. 1987;84(24):8879–8882. doi:10.1073/pnas.84.24.8879.
   PubMed Web of Science ®Google Scholar
• Feinstein TN, Wehbi VL, Ardura JA, Wheeler DS, Ferrandon S, Gardella TJ, Vilardaga JP. Retromer terminates the generation of cAMP by internalized PTH receptors. Nat Chem Biol. 2011 May;7(5):278–284. doi:10.1038/nchembio.545.
   PubMed Web of Science ®Google Scholar
• Sutkeviciute I, Vilardaga JP. Structural insights into emergent signaling modes of G protein-coupled receptors. J Biol Chem. 2020;295(33):11626–11642. doi:10.1074/jbc.REV120.009348.
   PubMed Web of Science ®Google Scholar
• Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science. 1999;286(5449):2495–2498. doi:10.1126/science.286.5449.2495.
   PubMed Web of Science ®Google Scholar
• Ferrari SL, Pierroz DD, Glatt V, Goddard DS, Bianchi EN, Lin FT, Manen D, Bouxsein ML. Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-arrestin2. Endocrinology. 2005;146(4):1854–1862. doi:10.1210/en.2004-1282.
   PubMed Web of Science ®Google Scholar
• Bouxsein ML, Pierroz DD, Glatt V, Goddard DS, Cavat F, Rizzoli R, Ferrari SL. Beta-arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice. J Bone Miner Res. 2005;20(4):635–643. doi:10.1359/JBMR.041204.
   PubMed Web of Science ®Google Scholar
• Iida-Klein A, Lu SS, Kapadia R, Burkhart M, Moreno A, Dempster DW, Lindsay R. Short-term continuous infusion of human parathyroid hormone 1-34 fragment is catabolic with decreased trabecular connectivity density accompanied by hypercalcemia in C57BL/J6 mice. J Endocrinol. 2005;186(3):549–557. doi:10.1677/joe.1.06270.
   PubMed Web of Science ®Google Scholar
• Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt AM. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res. 2012;28(1):2–17. doi:10.1002/jbmr.1805.
   Web of Science ®Google Scholar
• Bergwitz C, Jüppner H. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med. 2010;61(1):91–104. doi:10.1146/annurev.med.051308.111339.
   PubMedGoogle Scholar
• Zhang L, Lee KK, Sugamori KS, Grynpas MD, Mitchell J. Increased osteoblast GαS level determines bone response to hyperparathyroidism in female mice. J Endocrinol. 2022;254(1):13–26. doi:10.1530/JOE-22-0045.
   PubMed Web of Science ®Google Scholar
• Robling AG, Kedlaya R, Ellis SN, Childress PJ, Bidwell JP, Bellido T, Turner CH. Anabolic and catabolic regimens of human parathyroid hormone 1-34 elicit bone- and envelope-specific attenuation of skeletal effects in sost-deficient mice. Endocrinology. 2011;152(8):2963–2975. doi:10.1210/en.2011-0049.
   PubMed Web of Science ®Google Scholar
• Castellano E, Attanasio R, Boriano A, Pellegrino M, Garino F, Gianotti L, Borretta G. Sex difference in the clinical presentation of primary hyperparathyroidism: influence of menopausal status. J Clin Endocrinol Metab. 2017;102(11):4148–4152. doi:10.1210/jc.2017-01080.
   PubMed Web of Science ®Google Scholar
• Vodopivec DM, Silva AM, Garcia-Banigan DC, Christakis I, Stewart A, Schwarz K, Hussey CS, Bassett R, Hu MI, Perrier ND. Gender differences in bone mineral density in patients with sporadic primary hyperparathyroidism. Endocrinol Diabetes Metab. 2018;1(4):e00037. doi:10.1002/edm2.37.
   PubMedGoogle Scholar
• Grey AB, Stapleton JP, Evans MC, Tatnell MA, Reid IR. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial. Ann Intern Med. 1996;125(5):360–368. doi:10.7326/0003-4819-125-5-199609010-00002.
   PubMed Web of Science ®Google Scholar
• Kulak CA, Baz-Hecht M, Nieves J, Shen V, Lindsay R, Cosman F. Responses of urinary N-telopeptide and renal calcium handling to PTH infusion after treatment with estrogen, raloxifene, and tamoxifen. Calcif Tissue Int. 2012;90(4):263–271. doi:10.1007/s00223-012-9572-y.
   PubMed Web of Science ®Google Scholar
• Shen V, Birchman R, Wu DD, Lindsay R. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion. J Bone Miner Res. 2000;15(4):740–746. doi:10.1359/jbmr.2000.15.4.740.
   PubMed Web of Science ®Google Scholar
• Babey M, Wang Y, Kubota T, Fong C, Menendez A, ElAlieh HZ, Bikle DD. Gender-specific differences in the skeletal response to continuous PTH in mice lacking the IGF1 receptor in mature osteoblasts. J Bone Miner Res. 2015;30(6):1064–1076. doi:10.1002/jbmr.2433.
   PubMed Web of Science ®Google Scholar
• Christensen MH, Fenne IS, Flågeng MH, Almås B, Lien EA, Mellgren G. Estradiol determines the effects of PTH on ERα-dependent transcription in MC3T3-E1 cells. Biochem Biophys Res Commun. 2014;450(1):360–365. doi:10.1016/j.bbrc.2014.05.109.
   PubMed Web of Science ®Google Scholar
• Partridge NC, Bloch SR, Pearman AT. Signal transduction pathways mediating parathyroid hormone regulation of osteoblastic gene expression. J Cell Biochem. 1994;55(3):321–327. doi:10.1002/jcb.240550308.
   PubMed Web of Science ®Google Scholar
• Bastepe M, Turan S, He Q. Heterotrimeric G proteins in the control of parathyroid hormone actions. J Mol Endocrinol. 2017;58(4):R203–224. doi:10.1530/JME-16-0221.
   PubMed Web of Science ®Google Scholar
• Erclik MS, Mitchell J. The role of protein kinase C-delta in PTH stimulation of IGF-binding protein-5 mRNA in UMR-106-01 cells. Am J Physiol Endocrinol Metab. 2002;282(3):E534–541. doi:10.1152/ajpendo.00417.2001.
   PubMed Web of Science ®Google Scholar
• Blind E, Bambino T, Huang Z, Bliziotes M, Nissenson RA. Phosphorylation of the cytoplasmic tail of the PTH/PTHrP receptor. J Bone Miner Res. 1996;11(5):578–586. doi:10.1002/jbmr.5650110505.
   PubMed Web of Science ®Google Scholar
• Zindel D, Engel S, Bottrill AR, Pin J-P, Prézeau L, Tobin AB, Bünemann M, Krasel C, Butcher AJ. Identification of key phosphorylation sites in PTH1R that determine arrestin3 binding and fine-tune receptor signaling. Biochem J. 2016;473(22):4173–4192. doi:10.1042/BCJ20160740.
   PubMedGoogle Scholar
• Ferrari SL, Behar V, Chorev M, Rosenblatt M, Bisello A. Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves beta-arrestin2. Real-time monitoring by fluorescence microscopy. J Biol Chem. 1999;274(42):29968–29975. doi:10.1074/jbc.274.42.29968.
   PubMed Web of Science ®Google Scholar
• Gesty-Palmer D, Flannery P, Yuan L, Corsino L, Spurney R, Lefkowitz RJ, Luttrell LM. A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci Transl Med. 2009;1(1):1ra1. doi:10.1126/scitranslmed.3000071.
   PubMed Web of Science ®Google Scholar
• Nagai S, Okazaki M, Segawa H, Bergwitz C, Dean T, Potts JT, Mahon MJ, Gardella TJ, Jüppner H. Acute down-regulation of sodium-dependent phosphate transporter NPT2a involves predominantly the cAMP/PKA pathway as revealed by signaling-selective parathyroid hormone analogs. J Biol Chem. 2011;286(2):1618–1626. doi:10.1074/jbc.M110.198416.
   PubMed Web of Science ®Google Scholar
• Iida-Klein A, Zhou H, Lu SS, Levine LR, Ducayen-Knowles M, Dempster DW, Nieves J, Lindsay R. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. J Bone Miner Res. 2002;17(5):808–816. doi:10.1359/jbmr.2002.17.5.808.
   PubMed Web of Science ®Google Scholar
• Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, Saxton JM, Kronenberg HM, Baron R, Schipani E. Activated parathyroid hormone/parathyroid hormone–related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest. 2001;107(3):277–286. doi:10.1172/JCI11296.
   PubMed Web of Science ®Google Scholar